Details up front: phosphate-buffered diluent · five days.
I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has checked.
Assume no laboratory access beyond what I can pay a third party for.
Concretely, what should I do, and how would I know afterwards whether I did it right?
5 days is 0.18 times the twenty-eight days conventionally allowed for a preserved multi-dose vial once it has been entered. That convention assumes a preservative. Phosphate-buffered diluent has none, which makes it a single-entry preparation — its clock runs in hours after piercing, and 5 days is 120 of them. So the twenty-eight-day arithmetic never applied, and 0.18 times a figure that was never yours is not a reassurance. Growth at the densities that matter is not visible, so inspection is not the check people take it for. Date the vial at first entry and mark the punctures on the label; both cost nothing and both are the evidence you will want later.
The distinction that resolves most of these questions is understanding that bacteriostatic water is a preservative system for multi-withdrawal presentations, not a substitute for aseptic technique.
Benzyl alcohol concentration at 0.9 per cent is the approved level — lower concentrations do not provide the same suppression and higher concentrations are unnecessarily irritant.
| Vial | Diluent | Concentration | 0.25 mg | 0.5 mg | 1 mg | 2.5 mg |
|---|---|---|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 5 mg | 2 mL | 2.5 mg/mL | 10 u | 20 u | 40 u | 100 u |
| 10 mg | 1 mL | 10 mg/mL | 2.5 u | 5 u | 10 u | 25 u |
| 10 mg | 2 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 10 mg | 3 mL | 3.33 mg/mL | 7.5 u | 15 u | 30 u | 75 u |
Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.
A vial that has been sitting out at room temperature is not sterile and bacteriostatic water does not make it so.
Published pharmacopeial standards specify the use and limits of benzyl alcohol in preserved presentations.
Worth noting that some people have reactions to benzyl alcohol, which is worth knowing if you are going to inject.
If you are doing single-withdrawal use, sterile water is the better choice.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsNone of this is medical advice, and research-use-only material carries no regulatory approval.
The additive suppresses Gram-positive bacteria, Gram-negative bacteria and fungi quite effectively, but it is not an adequate control for spore-forming organisms.
A vial opened and then refrigerated has better preservation properties than one opened and left at room temperature, which has better properties than one opened and left warm.
The 28-day beyond-use convention derives from USP standards, which base it on microbiological risk rather than on any one specific study.
Do not use bacteriostatic water as a substitute for aseptic technique.
Bacteriostatic water is water for injection containing roughly 0.9 per cent benzyl alcohol as a preservative, and its purpose is to suppress microbial growth in a vial opened repeatedly.
Opened vials accumulate bioburden with every pierce, and benzyl alcohol suppresses the growth of the organisms that get in but does not prevent them getting in.
The osmolarity of bacteriostatic water is roughly that of normal saline, which makes it generally safe for subcutaneous or parenteral use.
Benzyl alcohol efficacy in suppressing common skin and environmental bacteria is well-established and published.
The limitation is that preservatives work when they work and fail when they are overwhelmed, and you have no way to know which case you are in without testing.
The practical summary: use bacteriostatic water for multi-withdrawal, store refrigerated, and respect the 28-day limit.
In practice, the 28-day figure comes from convention and from the preservative efficacy data, not from a stability study of every possible peptide, so it is a guideline and not a guarantee.
Do not rely on the preservative as a substitute for aseptic technique — it is a backstop, not a primary control.
The caveat is that bacteriostatic water is not sterile water for injection — they are different products with different purposes.
Write the arithmetic on the vial label. It costs nothing and it removes the step where you reconstruct it from memory at an inconvenient moment.
Concretely, bacteriostatic water is appropriate for reconstituted peptide solutions that you will draw from repeatedly over days or weeks, and inappropriate for single-draw presentations.
A vial of bacteriostatic water is sterile when you receive it — the challenge is keeping it that way as you draw from it repeatedly.
The general principle here — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science, and it is why licensed presentations contain a surfactant such as polysorbate 20 or 80. A research vial does not, which is precisely why handling matters more, not less.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale against the barrel rather than against your assumption.
edited 21 Mar 2026 by aine_mulcahy — clarified the distinction between purity and content
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.